Jaeger, A.
Prieske, K.
Mathey, S.
Fischer, I.
Vettorazzi, E.
Kuerti, S.
Reuter, S.
Dieckmann, J.
Schmalfeldt, B.
Woelber, L. http://orcid.org/0000-0002-9578-3049
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 19 December 2020
Accepted: 21 July 2021
First Online: 13 August 2021
Declarations
:
: AJ reports personal fees from Astra Zeneca, personal fees from Molecular Health, personal fees from Gsk, personal fees from Roche, personal fees from Clovis Oncology, personal fees from MSD, outside the submitted work. KP reports personal fees from AstraZeneca, personal fees from MSK, personal fees from Molecular health, personal fees from Gsk, personal fees from Roche, personal fees from Clovis Oncology, outside the submitted work. LW reports personal fees from med update GmbH, grants, personal fees and non-financial support from medac oncology, personal fees from promedics GmbH, grants, personal fees and non-financial support from Roche, grants, personal fees and non-financial support from Tesaro, personal fees from Teva, personal fees from OmniaMed, personal fees from Pfizer, personal fees from Greiner, outside the submitted work.
: The study was approved by the local Ethics Committee (Ethics Committee of the Medical Board Hamburg Reference Number: 190504).
: Informed consent had been obtained from all included patients according to our investigational review board and ethics committee guidelines, Ethics Committee of the Medical Board Hamburg Reference Number: 190504.